PT862454E - Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados - Google Patents

Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados

Info

Publication number: PT862454E
Authority: PT; Portugal
Prior art keywords: ctla; mamifero; new uses; related reagents; methods
Prior art date: 1995-10-27

Application number

PT96936385T

Other languages

English (en)

Inventor

Jacques Banchereau

Odille Djossou

Leopoldo Flores-Romo

Francois Fossiez

Pirre Golstein

Mala Krishna

Serge J E Lebecque

Richard Murray

Original Assignee

Inst Nat La Sante Et La Rech M

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-27

Filing date

1996-10-23

Publication date

2002-11-29

1996-10-23 Application filed by Inst Nat La Sante Et La Rech M, Schering Corp filed Critical Inst Nat La Sante Et La Rech M

2002-11-29 Publication of PT862454E publication Critical patent/PT862454E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Zoology (AREA)
Virology (AREA)
Diabetes (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT96936385T 1995-10-27 1996-10-23 Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados PT862454E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US590995P	1995-10-27	1995-10-27
US56974295A	1995-12-08	1995-12-08

Publications (1)

Publication Number	Publication Date
PT862454E true PT862454E (pt)	2002-11-29

Family

ID=26674918

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96936385T PT862454E (pt)	1995-10-27	1996-10-23	Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados

Country Status (11)

Country	Link
EP (1)	EP0862454B1 (pt)
JP (2)	JP3253633B2 (pt)
AT (1)	ATE222768T1 (pt)
AU (1)	AU7439996A (pt)
CA (1)	CA2235951C (pt)
DE (1)	DE69623316T2 (pt)
DK (1)	DK0862454T3 (pt)
ES (1)	ES2181915T3 (pt)
HK (1)	HK1015692A1 (pt)
PT (1)	PT862454E (pt)
WO (1)	WO1997015320A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0417487D0 (en)	2004-08-05	2004-09-08	Novartis Ag	Organic compound
US7790163B2 (en)	2006-03-10	2010-09-07	Zymogenetics, Inc.	Antibodies that bind both IL-17A and IL-17F and methods of using the same
JP2009534297A (ja)	2006-03-10	2009-09-24	ザイモジェネティクス，インコーポレイテッド	Ｉｌ−１７ａおよびｉｌ−１７ｆの両方に結合する抗体ならびにその使用方法
WO2008134659A2 (en)	2007-04-27	2008-11-06	Zymogenetics, Inc.	Antagonists to il-17a, il-17f, and il-23p19 and methods of use
AU2009296299A1 (en)	2008-09-29	2010-04-01	Roche Glycart Ag	Antibodies against human IL 17 and uses thereof
US20100310502A1 (en) *	2009-06-09	2010-12-09	Anders Linden	Method of treating local infections in mammals
EP2834273B1 (en)	2012-04-05	2018-08-22	F.Hoffmann-La Roche Ag	Bispecific antibodies against human tweak and human il17 and uses thereof
WO2014161570A1 (en)	2013-04-03	2014-10-09	Roche Glycart Ag	Antibodies against human il17 and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL96477A0 (en) *	1989-12-01	1991-08-16	Amgen Inc	Megakaryocyte production
ATE190497T1 (de) *	1990-08-23	2000-04-15	Chiron Corp	Verwendung des rekombinanten koloniestimulierenden faktors-1
US6562333B1 (en) *	1993-06-14	2003-05-13	Schering Corporation	Purified mammalian CTLA-8 antigens and related reagents
EP0734265A1 (en) *	1993-12-13	1996-10-02	Novartis AG	Il-6 therapy

1996
- 1996-10-23 PT PT96936385T patent/PT862454E/pt unknown
- 1996-10-23 JP JP51663197A patent/JP3253633B2/ja not_active Expired - Fee Related
- 1996-10-23 EP EP96936385A patent/EP0862454B1/en not_active Expired - Lifetime
- 1996-10-23 AU AU74399/96A patent/AU7439996A/en not_active Abandoned
- 1996-10-23 DE DE69623316T patent/DE69623316T2/de not_active Expired - Fee Related
- 1996-10-23 CA CA002235951A patent/CA2235951C/en not_active Expired - Fee Related
- 1996-10-23 WO PCT/US1996/016315 patent/WO1997015320A1/en active IP Right Grant
- 1996-10-23 AT AT96936385T patent/ATE222768T1/de not_active IP Right Cessation
- 1996-10-23 ES ES96936385T patent/ES2181915T3/es not_active Expired - Lifetime
- 1996-10-23 DK DK96936385T patent/DK0862454T3/da active
1999
- 1999-02-27 HK HK99100811A patent/HK1015692A1/xx not_active IP Right Cessation
2001
- 2001-09-11 JP JP2001275810A patent/JP2002145799A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2235951A1 (en)	1997-05-01
WO1997015320A1 (en)	1997-05-01
AU7439996A (en)	1997-05-15
ATE222768T1 (de)	2002-09-15
DE69623316D1 (de)	2002-10-02
JPH10512293A (ja)	1998-11-24
HK1015692A1 (en)	1999-10-22
JP2002145799A (ja)	2002-05-22
JP3253633B2 (ja)	2002-02-04
DK0862454T3 (da)	2002-12-30
CA2235951C (en)	2003-04-01
DE69623316T2 (de)	2003-04-17
EP0862454A1 (en)	1998-09-09
EP0862454B1 (en)	2002-08-28
ES2181915T3 (es)	2003-03-01

Similar Documents

Publication	Publication Date	Title
IL267381A (en)	2019-08-29	A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
PT891331E (pt)	2004-02-27	Derivados do acido n-(2-oxoacetil ou sulfonil)-pirrolidino/piperidina-2-carboxilico com actividade melhorada de resistencia a multifarmacos
CY1107314T1 (el)	2012-11-21	Μεθοδος θεpαπευτικης αγωγης ασθενων προσβεβλημενων με σκληρυνση κατα πλακας χρησιμοποιωντας συναινετικη ιντepφepονη
MY119403A (en)	2005-05-31	Novel compounds with analgesic effect.
DK0841949T3 (da)	2006-08-21	Anvendelse af saccharid-konjugater
MY115662A (en)	2003-08-30	Novel compounds with analgesic effect
BR9909277A (pt)	2001-10-16	Compostos com atividade em receptores muscarìnicos
MX9703621A (es)	1997-08-30	Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
DE60128912D1 (en)	2007-07-26	Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
BR9803233A (pt)	2000-05-02	Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares.
BR9809678A (pt)	2000-07-11	Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
PT862454E (pt)	2002-11-29	Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados
DK0680323T3 (da)	1997-10-20	Synergistisk kombination med antagonistvirkning ved NK1- og Nk2-receptorer.
WO2001017558A3 (en)	2001-09-27	Novel uses of mammalian ccr6 receptors and related reagents
BRPI0409699A (pt)	2006-04-18	métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
NO982863L (no)	1998-06-19	Nye forbindelser med analgetisk effekt
WO2000061171A3 (en)	2001-01-25	Uses of mammalian ox2 protein and related reagents
TR200000461T2 (tr)	2000-09-21	Bir transdermal terapötik sistemin suistimalinin önlenmesini sağlayan işlem.
NO953003L (no)	1996-01-30	Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
BR9801839A (pt)	2000-01-18	Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
ATE271867T1 (de)	2004-08-15	Behandlung der harninkontinenz und zusammenstellung dafür
PT1313500E (pt)	2005-02-28	Associacoes de dalfopristina/quinupristina com o cefpirome
UA43389C2 (uk)	2001-12-17	Спосіб зниження рівнів кальцію у сироватці